Table 2.
Overview of good quality (coverage >15 and ≤50% genotypes missing) samples included in the Pv AmpliSeq analysis.
| WHO Region | Country | n | percent of total | years |
| unknown | 2 | 0.51 | 2020 (1) | |
| AFR (n=29; 7.4%) | Burundi | 1 | 0.25 | 2019 |
| DRC | 1 | 0.25 | 2019 | |
| Eritrea | 12 | 3.05 | 2014, 2015, 2016 | |
| Ethiopia | 13 | 3.30 | 2012, 2013, 2014, 2015, 2016, 2019 | |
| Mauritania | 1 | 0.25 | 2013 | |
| Senegal | 1 | 0.25 | 2012 | |
| AMR (n=24; 6.1%) | Brazil | 2 | 0.51 | 2016, 2019 |
| Colombia | 4 | 1.02 | 2014, 2015, 2019 | |
| Guyana | 3 | 0.76 | 2013, 2014, 2015 | |
| Panama | 2 | 0.51 | 2013 | |
| Peru | 13 | 3.30 | 2008 | |
| EMR (n=37; 9.4%) | Afghanistan | 16 | 4.06 | 2012, 2013, 2015, 2016, 2017, 2018, 2019 |
| Pakistan | 13 | 3.30 | 2014, 2015, 2016, 2017,2 018, 2019 | |
| Somalia | 1 | 0.25 | 2016 | |
| Sudan | 7 | 1.78 | 2015, 2019 | |
| EUR (n=1; 0.3%) | Spain | 1 | 0.25 | 2016 |
| SEAR (n= 27; 6.9%) | Bangladesh | 3 | 0.76 | 2014, 2015 |
| Bhutan | 2 | 0.51 | 2014 | |
| India | 15 | 3.81 | 2011, 2012, 2013, 2014, 2015, 2017, 2018 | |
| Indonesia | 5 | 1.27 | 2010, 2012, 2013, 2016, 2017 | |
| Thailand | 2 | 0.51 | 2006, 2007 | |
| WPRO (n=274; 69.5%; without VTN n= 13; 3.3%) | Cambodia | 1 | 0.25 | 2018 |
| China | 2 | 0.51 | 2009, 2011 | |
| Malaysia | 3 | 0.76 | 2014 | |
| Papua New Guinea | 5 | 1.27 | 2010, 2012, 2013, 2014, 2019 | |
| Philippines | 1 | 0.25 | 2015 | |
| Singapore | 1 | 0.25 | 2015 | |
| Vietnam | 261 | 66.24 | 2015, 2016, 2017, 2018, 2019 | |
| ALL | 28 countries | 394 | 100% | 2006 - 2020 |